Aperture Therapeutics is a biotechnology research company founded in 2022 and headquartered in San Carlos, California. The company is building an innovative drug discovery platform that leverages patient genetic diversity and mechanistic insights.
Subscribe to see Aperture Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Aperture Therapeutics is a biotechnology company headquartered in San Carlos, United States. Its most recent funding round, Grant, closed in July 2024. Xcout tracks 2 named people at Aperture Therapeutics, including Therése Dalebrant (CHIEF OF STAFF).
As of 16 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Grant | Undisclosed | 9 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Aperture Therapeutics's closest competitors — see the full list of competitors and alternatives →
Sift Biosciences is a privately held biotechnology company founded in 2024 and headquartered in San Carlos, California. The company is focused on harnessing pre-existing hidden immunity.
Spring Discovery (also known as Spring Science) is a biotechnology research company founded in 2017 and based in San Carlos, California. The company focuses on therapeutics and drug discovery targeting age-related diseases.
Olio Labs is a biotechnology research company headquartered in South San Francisco, California, operating a discovery platform that connects human outcomes, target discovery, and target validation.
RAPT Therapeutics is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California. Founded in 2015, the public company leverages its proprietary drug discovery platform to develop treatments for inflammatory and immunologic diseases.
Sculpta Bio is a biotechnology research company headquartered in San Francisco, California, known as the Protein Sculpting Company.
Sharp Therapeutics Corp. is a preclinical-stage biotechnology and drug discovery company that develops small molecule therapies to treat genetic diseases and hereditary disorders. The company combines high-speed experimentation and computational methods to advance its drug discovery platform.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Aperture Therapeutics? Suggest a correction · Work at Aperture Therapeutics? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.